After four years of successful commercial growth, Brunswick MedTech has invested in a permanent location and facilities. Jon Avent, CEO, said: 'our stability directly affects that of our customers. To be in a permanent location where we are the owners means that we can drive greater efficiencies, provide even greater quality and offer significant scalability options.' The Brunswick MedTech team have worked hard to ensure continuity of service - and even welcomed some new customers for our order fulfilment services.

Brunswick MedTech has won a commercialisation project for a falls prevention technology which is a Lancaster University research 'spin-out'. The Brunswick MedTech team will be working with existing teams to engage with clinical and operational teams across the NHS and Private Provider landscape to deploy the technology and prevent patients falling out of bed. Jon Avent, CEO, said: 'as the patient population is ageing, technologies like this become even more important to develop and deploy - helping both clinical teams and the patient reduce injuries. Our network, efficiency and proactive skills will ensure a better future for all'.

We are proud to work with a world-class AI 'spin-out' from Oxford University, helping them with commercialising a world-first AI solution. Jon Avent, CEO said: 'Working with this company pre-launch to define marketing and pricing strategies is really exciting - it's why I founded Brunswick MedTech - to help world-class research turn in to products that help patients and clinicians.' If you'd like to know more about how we help all sizes of companies expand their business - please email info@brunswickmed.co.uk